Status: Recruiting
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
A multicentre, interventional, multi-arm, multi-stage Phase 3 trial including randomisation, double blinding, placebo control evaluation of treatments for sustained clinical response (18 months) in symptomatic Alzheimer's Disease in a population representative of people with Alzheimer's disease in the UK.
Participants needed: 1,200
Trial details
Phase: Phase 3Age: 55+Biological sex: AllType: InterventionalSponsor: University College, LondonUpdated: Jul 23, 2026Locations: 2
Eligibility criteria
Confirmed clinical diagnosis of Alzheimer's Disease (AD) [+14]
Fazekas Score =3 reported from an MRI taken at any time prior to randomisation,... [+23]